Mary Yaroshevsky-Glanville
Director/Board Member bei Biotech Employee Development Coalition
Profil
Mary Yaroshevsky-Glanville is currently the Director at the Biotech Employee Development Coalition and the Director at the Project Athena Foundation.
Previously, she held the position of Director-Human Resources at 1322256 Alberta Ltd.
from 1994 to 2000 and at EACOM Timber Corp.
in 2001.
She also served as the Director at the Society Of Human Resources Management and the Bay Area Organization Development Network.
From 2001 to 2009, Mary was the Vice President-Human Capital at Anadys Pharmaceuticals, Inc. and later became the Senior Vice President-Human Capital at Regulus Therapeutics, Inc. Ms. Yaroshevsky-Glanville completed her undergraduate degree at DeVry University and DeVry Institute of Technology.
Aktive Positionen von Mary Yaroshevsky-Glanville
Unternehmen | Position | Beginn |
---|---|---|
Biotech Employee Development Coalition | Director/Board Member | - |
Project Athena Foundation | Director/Board Member | - |
Ehemalige bekannte Positionen von Mary Yaroshevsky-Glanville
Unternehmen | Position | Ende |
---|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Corporate Officer/Principal | 30.09.2009 |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Human Resources Officer | 01.01.2001 |
1322256 Alberta Ltd.
1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. | Human Resources Officer | 01.01.2000 |
Bay Area Organization Development Network | Director/Board Member | - |
Society Of Human Resources Management | Director/Board Member | - |
Ausbildung von Mary Yaroshevsky-Glanville
DeVry University | Undergraduate Degree |
DeVry Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REGULUS THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
1322256 Alberta Ltd.
1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. | Health Technology |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Society Of Human Resources Management | |
Biotech Employee Development Coalition | |
Project Athena Foundation | |
Bay Area Organization Development Network |